A detailed history of Cibc Private Wealth Group, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,000 shares of TERN stock, worth $11,920. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 1,000 100.0%
Holding current value
$11,920
Previous $6,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.49 - $10.8 $6,490 - $10,800
1,000 Added 100.0%
2,000 $16,000
Q2 2024

Aug 09, 2024

BUY
$4.54 - $8.2 $4,086 - $7,379
900 Added 900.0%
1,000 $6,000
Q1 2024

May 10, 2024

BUY
$4.86 - $8.19 $486 - $819
100 New
100 $0

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $224M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.